Halozyme Therapeutics
HALO
$33.57
Share price
3.32%
Change (1 day)
-24.48%
Change (1 year)
Categories
Halozyme Therapeutics (HALO) Fails to deliver data
Key failure to deliver metrics for Halozyme Therapeutics:
- Last SEC data release: 2023-05-12
- Last 15 days FTD volume: $2.5 M
- Last 3 months FTD volume: $16.57 M
- Last year FTD volume: $42.69 M
Failures to deliver for Halozyme Therapeutics (HALO) - 3 month history
Number of shares, 3 month chartBiweekly Failures to deliver volume for Halozyme Therapeutics (HALO) - since 2013
Volume in USD (price x number of shares), data since 2013Halozyme Therapeutics (HALO) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2023 | $18.77 M | -37.86% |
| 2022 | $30.2 M | 38.39% |
| 2021 | $21.82 M | -6.23% |
| 2020 | $23.27 M | -44.23% |
| 2019 | $41.74 M | 591.9% |
| 2018 | $6.03 M | -64.48% |
| 2017 | $16.98 M | -5.65% |
| 2016 | $17.99 M | -13.05% |
| 2015 | $20.7 M | -7.81% |
| 2014 | $22.45 M | 140.61% |
| 2013 | $9.33 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $48.88 M | $0.24 B | 🇺🇸 USA |
 Pfizer PFE | $33.95 M | $0.52 B | 🇺🇸 USA |
 Eli Lilly LLY | $35.38 M | $0.21 B | 🇺🇸 USA |
 Sanofi SNY | $7.71 M | $0.11 B | 🇫🇷 France |
 Baxter BAX | $0.14 B | $0.16 B | 🇺🇸 USA |
 MannKind Corp MNKD | $5.84 M | $23.59 M | 🇺🇸 USA |